You can find the annual or quarterly income statement of Coeptis Therapeutics Holdings Inc here for insights into the performance and operational efficiency of Coeptis Therapeutics Holdings Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2019Q4

FY2019Q3

Total revenue

--237.44K

--200.68K

--62.87K

--0.00

----

Revenue

--237.44K

--200.68K

--62.87K

--0.00

----

Cost of revenue

18.06%295.15K

18.06%295.16K

--295.16K

--250.00K

-5.66%250.00K

0.00%250.00K

----

-100.00%0.00

231.25%265.00K

4900.00%250.00K

----

--90.00K

--80.00K

--5.00K

----

Operating expenses

26.74%2.71M

66.96%4.72M

40.98%4.12M

-35.76%2.16M

-72.94%2.14M

-23.25%2.83M

-55.31%2.92M

-89.63%3.37M

41.56%7.92M

-62.22%3.68M

-58.39%6.54M

11329.13%32.47M

5491.34%5.59M

6165.11%9.75M

11004.82%15.72M

--284.10K

199934.00%100.02K

--155.69K

--141.52K

----

--50.00

----

R&D expenses

-27.66%587.28K

-27.21%290.31K

-88.85%86.66K

-66.07%343.88K

-84.00%811.78K

-14.53%398.82K

573.78%777.07K

4751.57%1.01M

24187.54%5.07M

--466.63K

--115.33K

--20.89K

--0.00

----

Depreciation, depletion, and amortization

6.14%295.30K

18.02%295.30K

22.02%305.30K

3.86%259.98K

11.15%278.23K

-0.04%250.21K

-75.00%250.31K

--250.31K

--1.00M

--0.00

----

Other operating expenses

----

-739.31%-1.82M

----

--284.10K

199934.00%100.02K

--155.69K

--141.52K

----

--50.00

----

Operating profit

-15.65%-2.48M

-59.87%-4.52M

-38.82%-4.06M

35.76%-2.16M

72.94%-2.14M

23.25%-2.83M

55.31%-2.92M

89.63%-3.37M

-41.56%-7.92M

62.22%-3.68M

58.39%-6.54M

-11329.13%-32.47M

-5491.34%-5.59M

-6165.11%-9.75M

-11004.82%-15.72M

---284.10K

-199934.00%-100.02K

---155.69K

---141.52K

----

---50.00

----

Net non-operating interest income (expenses)

Non-operating interest income

----

--1.91K

--1.89K

--1.87K

----

--0.00

----

Non-operating interest expense

22.94%62.61K

2.62%67.79K

-64.34%71.49K

468.46%78.63K

157.20%50.93K

54.93%66.06K

538.21%200.50K

-96.71%13.83K

-64.91%19.80K

-33.20%42.64K

-43.72%31.42K

--420.39K

--56.42K

--63.83K

--55.82K

----

Gains from sale of securities

---568.87K

----

Special income (expenses)

-81.50%57.75K

497.24%592.88K

1609.30%596.12K

-334.26%-776.78K

-80.60%312.24K

-128.43%-149.25K

102.51%34.88K

97.60%-178.88K

--1.61M

3396.04%525.00K

59.29%-1.39M

-698.01%-7.46M

-100.00%0.00

100.91%15.02K

-123.98%-3.41M

---934.50K

--4.28M

---1.65M

--14.21M

----

- Gains from disposal of fixed assets

----

--0.00

----

--0.00

----

Other non-operating income (expenses)

194.80%151.99K

-4297.69%-338.46K

28.62%111.41K

102.98%5.86K

318.48%51.56K

--8.06K

247400.00%86.63K

93.59%-196.91K

---23.60K

--0.00

--35.00

-21929721.43%-3.07M

-100.00%0.00

--0.00

--14.00

--16.00

--41.00

--0.00

----

Income before tax

-58.50%-2.90M

-42.80%-4.33M

-13.98%-3.42M

19.81%-3.01M

71.20%-1.83M

5.22%-3.04M

62.28%-3.00M

90.67%-3.76M

-12.42%-6.35M

67.33%-3.20M

58.51%-7.96M

-3208.13%-40.25M

-235.24%-5.65M

-443.47%-9.80M

-236.29%-19.18M

---1.22M

8353918.00%4.18M

---1.80M

--14.07M

----

---50.00

----

Income tax

--0.00

----

--0.00

----

Income after tax

-58.50%-2.90M

-42.80%-4.33M

-13.98%-3.42M

19.81%-3.01M

71.20%-1.83M

5.22%-3.04M

62.28%-3.00M

90.67%-3.76M

-12.42%-6.35M

67.33%-3.20M

58.51%-7.96M

-3208.13%-40.25M

-235.24%-5.65M

-443.47%-9.80M

-236.29%-19.18M

---1.22M

8353918.00%4.18M

---1.80M

--14.07M

----

---50.00

----

Net income from continuous operations

-58.50%-2.90M

-42.80%-4.33M

-13.98%-3.42M

19.81%-3.01M

71.20%-1.83M

5.22%-3.04M

62.28%-3.00M

90.67%-3.76M

-12.42%-6.35M

67.33%-3.20M

58.51%-7.96M

-3208.13%-40.25M

-235.24%-5.65M

-443.47%-9.80M

-236.29%-19.18M

---1.22M

8353918.00%4.18M

---1.80M

--14.07M

----

---50.00

----

Other net gains and losses

--159.36K

----

Net Income attributable to non-controlling interests

---159.36K

---799.99K

---363.21K

---1.06M

--0.00

----

Net income attributable to controlling interests

-49.78%-2.74M

-16.45%-3.53M

-1.88%-3.06M

48.13%-1.95M

71.20%-1.83M

5.22%-3.04M

62.28%-3.00M

90.67%-3.76M

-12.42%-6.35M

67.33%-3.20M

58.51%-7.96M

-3208.13%-40.25M

-235.24%-5.65M

-443.47%-9.80M

-236.29%-19.18M

---1.22M

8353918.00%4.18M

---1.80M

--14.07M

----

---50.00

----

Net income attributable to common shareholders

-49.78%-2.74M

-16.45%-3.53M

-1.88%-3.06M

48.13%-1.95M

71.20%-1.83M

5.22%-3.04M

62.28%-3.00M

90.67%-3.76M

-12.42%-6.35M

67.33%-3.20M

58.51%-7.96M

-3208.13%-40.25M

-235.24%-5.65M

-443.47%-9.80M

-236.29%-19.18M

---1.22M

8353918.00%4.18M

---1.80M

--14.07M

----

---50.00

----

Basic earnings per share

37.18%-0.58

40.99%-0.95

41.08%-1.00

57.18%-0.95

80.72%-0.92

44.98%-1.62

78.69%-1.69

94.61%-2.22

43.24%-4.77

80.49%-2.94

73.96%-7.92

-1485.00%-41.14

-194.22%-8.40

-291.25%-15.06

-201.36%-30.43

92.96%-2.60

4455500.00%8.91

---3.85

--30.02

-1417684.62%-36.86

--0.00

Diluted earnings per share

37.18%-0.58

40.99%-0.95

41.08%-1.00

57.18%-0.95

80.72%-0.92

44.98%-1.62

78.69%-1.69

94.61%-2.22

43.24%-4.77

80.49%-2.94

73.96%-7.92

-1485.00%-41.14

-194.22%-8.40

-291.25%-15.06

-201.36%-30.43

92.96%-2.60

4455500.00%8.91

---3.85

--30.02

-1417684.62%-36.86

--0.00

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

